Skip to content

Clinical trial to evaluate the efficacy Of Mahamasha Oil Karanpooran(eardrops) and Syp.Mashabaladi Kwatha Orally in the management of Tinnitus

A RANDOMISED CONTROL CLINICAL TRIAL TO EVALUATE THE EFFICACY OF MAHAMASHA TAILA KARNAPOORNA AND MASHBALADI KWATHA ORALLY IN THE MANAGEMENT OF KARNANADA/TINNITUS - NIL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074947
Enrollment
102
Registered
2024-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H931- Tinnitus

Interventions

None listed

Sponsors

DR ASHLEKHA SHARMA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients between age of 16-65 years irrespective of age, sex, caste, religion etc. 2. Patients will selected on the basis of classical signs and symptoms of Karnanada (Tinnitus). 3. Subjective type of tinnitus. 4. Patients willing to be registered for trial.

Exclusion criteria

Exclusion criteria: 1.Congenital deformity of external/middle ear 2.Blockage due to stenosis of external auditory canal/wax 3.Established diabetes mellitus and hypertension 4.Pregnant and lactating mothers. 5.Cases which required surgical intervention 7. Severe hearing loss and patients not fulfilling the inclusion criteria.

Design outcomes

Primary

MeasureTime frame
Based upon the score of THI the classification of severity of tinnitus will be done: THI SCORE BAND LEVEL OF TINNITUS Timepoint: During the study of 60 days (Trial Treatment duration ) examination of the patient will be done on 0th, 7th ,30th day and 60th day. After completing the study of 60 days patient will be reassessed on 75th and 90th day. Time period of study per patient – 90 days

Secondary

MeasureTime frame
A. To access the safety profile of both the drugs. B. To access the compliance of both the drugs C. To compile & understand all the latest researches & treatments under trial for tinnitusTimepoint: Two months

Countries

India

Contacts

Public ContactDR ASHLEKHA SHARMA
drashukataria@gmail.com9416553131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026